αVβ3 integrin regulates heregulin (HRG)-induced cell proliferation and survival in breast cancer

[1]  Y. Liu,et al.  Targeted Mutagenesis of the Angiogenic Protein CCN1 (CYR61) , 2004, Journal of Biological Chemistry.

[2]  D. Griggs,et al.  A small molecule antagonist of the αvβ3 integrin suppresses MDA-MB-435 skeletal metastasis , 2004, Clinical & Experimental Metastasis.

[3]  Ming-Tsan Lin,et al.  Cyr61 Expression Confers Resistance to Apoptosis in Breast Cancer MCF-7 Cells by a Mechanism of NF-κB-dependent XIAP Up-Regulation* , 2004, Journal of Biological Chemistry.

[4]  H. Jin,et al.  Integrins: roles in cancer development and as treatment targets , 2004, British Journal of Cancer.

[5]  Joseph J. Pereira,et al.  Bimolecular Interaction of Insulin-Like Growth Factor (IGF) Binding Protein-2 with αvβ3 Negatively Modulates IGF-I-Mediated Migration and Tumor Growth 1 , 2004, Cancer Research.

[6]  D. Griggs,et al.  Anti-metastatic properties of RGD-peptidomimetic agents S137 and S247 , 2004, Clinical & Experimental Metastasis.

[7]  D. Stupack,et al.  Apoptotic cues from the extracellular matrix: regulators of angiogenesis , 2003, Oncogene.

[8]  A. Saven,et al.  Activated integrin αvβ3 cooperates with metalloproteinase MMP-9 in regulating migration of metastatic breast cancer cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[9]  S. Dedhar,et al.  αv integrins regulate cell proliferation through integrin-linked kinase (ILK) in ovarian cancer cells , 2003, Oncogene.

[10]  S. Blystone,et al.  Ligand-dependent Activation of Integrin αvβ3 * , 2003, The Journal of Biological Chemistry.

[11]  R. Lupu,et al.  Blockage of heregulin expression inhibits tumorigenicity and metastasis of breast cancer , 2003, Oncogene.

[12]  M. Roberts,et al.  ERK1 Associates with αvβ3 Integrin and Regulates Cell Spreading on Vitronectin* , 2003, The Journal of Biological Chemistry.

[13]  M. Dard,et al.  Structure and function of RGD peptides involved in bone biology , 2003, Cellular and Molecular Life Sciences CMLS.

[14]  A. Karsan,et al.  Activation of metalloproteinases and their association with integrins: an auxiliary apoptotic pathway in human endothelial cells , 2002, Cell Death and Differentiation.

[15]  L. Lau,et al.  Pro-angiogenic Activities of CYR61 (CCN1) Mediated through Integrins αvβ3 and α6β1 in Human Umbilical Vein Endothelial Cells* , 2002, The Journal of Biological Chemistry.

[16]  R. Lupu,et al.  Cyr61 promotes breast tumorigenesis and cancer progression , 2002, Oncogene.

[17]  David A. Cheresh,et al.  Get a ligand, get a life: integrins, signaling and cell survival , 2002, Journal of Cell Science.

[18]  N. Kieffer,et al.  Integrin αvβ3 expression confers on tumor cells a greater propensity to metastasize to bone , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[19]  J. Parsons,et al.  Integrin connections map: to infinity and beyond. , 2002, Science.

[20]  Martin A. Schwartz,et al.  Networks and crosstalk: integrin signalling spreads , 2002, Nature Cell Biology.

[21]  K. Messmer,et al.  Inhibition of the alpha-ν integrins with a cyclic RGD peptide impairs angiogenesis, growth and metastasis of solid tumours in vivo , 2002, British Journal of Cancer.

[22]  David A. Cheresh,et al.  Role of integrins in cell invasion and migration , 2002, Nature Reviews Cancer.

[23]  David A. Cheresh,et al.  Apoptosis of adherent cells by recruitment of caspase-8 to unligated integrins , 2001, The Journal of cell biology.

[24]  J W Smith,et al.  Integrin activation controls metastasis in human breast cancer. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[25]  M. Pierschbacher,et al.  Concept and progress in the development of RGD‐containing peptide pharmaceuticals , 1995, Biopolymers.

[26]  Richard O. Hynes,et al.  Integrins: Versatility, modulation, and signaling in cell adhesion , 1992, Cell.